Advisory Board

The Medtech Industry Advisory Board includes some of the leading authorities and executive management in regulatory affairs, clinical and quality for the medical device industry. Its purpose is to assist SCSU in setting the current and future direction/strategy for the MS-ACR, MS-MTQ, and MS-RAS programs, including changing industry needs and optimization of the programs to best meet these needs.

Industry Advisory Board Members

Vicki Bebeau
Vice President, Clinical Affairs

David Cannistraci
Vice President, Regulatory Affairs and Post Market Vigilance
Covidien Inc., Peripheral Vascular and Neurovascular Divisions

Suzanne Danielson
Director of Regulatory Affairs and Quality
3M Medical Division

Russ Davies
Vice President, Global Regulatory Affairs & Quality Systems
Smiths Medical

Will Donovan
Vice President, Quality
3M Drug Delivery Systems

Mark DuVal
President & Attorney
DuVal & Associates

Jeff Fecho
Vice President, Global Quality
St. Jude Medical

Patty Feulner
ACR Program Director

Larry Getlin
Consultant & former Senior Vice President Legal,
Corporate Compliance & Quality (retired)
American Medical Systems


Chris Harrold
Vice President of Quality
Medtronic Coronary and Structural Heart Disease Management

Debra Kridner
Executive VP Global Regulatory Affairs, Quality Assurance and Reimbursement
Sunshine Heart Inc.

Larry Kuusisto, Ph.D.
RAS Program Director
Vice President of Education (former)
LifeScience Alley

Michael Morton
Vice President, Corporate Regulatory Affairs
Medtronic, Inc.

Steve Norsted, Ph.D.
Regulatory and Clinical Research Institute, Inc. (RCRI)

Brian Novak
Vice President, Regulatory Affairs, Interventional Cardiology
Boston Scientific

Brian Rembish
MedTech Leadership, Inc.

Dan Schaber
VP of Clinical Research CRDM

Chuck Swanson, Ph.D.
RAS Program Director (retired)
Vice President of Regulatory Affairs (retired)

Mark Swanson
MTQ Program Director

Untitled Document